Efficacy and safety of sequential amoxicillin-clavulanate in the treatment of anaerobic lung infections

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 3, 2003, Pages 185-187

  Fernandez Sabe N ^a   Carratala J ^a   Dorca, J ^a   Roson B ^a   Tubau, F ^a   Manresa, F ^a   Gudiol, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ADULT; AGED; ANAEROBIC BACTERIUM; ANAEROBIC INFECTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; DIARRHEA; DOCUMENTATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FUSOBACTERIUM; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA; LACTOBACILLUS; LUNG ABSCESS; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROORGANISM; NAUSEA; NEISSERIA; PEPTOSTREPTOCOCCUS; PHLEBITIS; PORPHYROMONAS; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL; PROPIONIBACTERIUM; STREPTOCOCCUS SANGUINIS; VEILLONELLA; VOMITING;

EID: 0037364084     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0898-2     Document Type: Article

References (10)

1. Bartlett JG, Gorbach SL (1975) Treatment of aspiration pneumonia and primary lung abscess. Penicillin G vs clindamycin. JAMA 234:935-937
2. Levison ME, Mangura CT, Lorber B, Abrutyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR (1983) Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 98:466-471
3. Gudiol F, Manresa F, Pallares R, Dorca J, Rufi G, Boada J, Ariza X, Casanova A, Viladrich PF (1990) Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistantBacteroides melaninogenicus. Arch Intern Med 150:2525-2529
4. Bartlett JG (1993) Anaerobic bacterial infections of the lung and pleura space. Clin Infect Dis16 (Supp14):248-255
5. Barreiro B, Dorca J, Prats E, Manresa F, Martin R, Gudiol F (1994) Amoxicillin-clavulante vs clindamycin in the treatment of anaerobic lung infections. Eur Respir J 7 (Suppl18):447
6. National Committee for Clinical Laboratory Standards (1997) Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A4. NCCLS, Villanova, PA
7. Hammond J, Potgieter PD, Hanslo D, Scott H, Roditi D (1995) The etiology and antimicrobial susceptibility patterns of microorganisms in acute community-acquired lung abscess. Chest 108:937-941
8. Marina M, Strong CA, Civen R, Molitoris E, Finegold SM (1993) Bacteriology of anaerobic pleuropulmonary infections: preliminary report. Clin Infect Dis 16 (Suppl 4):256-262
9. Rosón B, Carratalià J, Tubau F, Dorca J, Liñares J, Pallares R, Manresa F, Gudiol F (2001) Usefulness of beta-lactam therapy for community-acquired pneumonia in the era of drug-resistantStreptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone. Microb Drug Resist 7:85-96
10. Germaud P, Poirier J, Jacqueme P, Guerin JC, Bernard Y, Boutin C, Brambilla C, Escamilla R, Zuck P (1993) Monothérapie par amoxicilline/acide clavulanique (AM-AC) en traitement de premiere intention dans les abcès pulmonaires communautaires. Rev Pneumol Clin 49:137-141